Record title

Results of a randomized, double-blind phase II clinical trial of NY-ESO-1 vaccine with ISCOMATRIX adjuvant versus ISCOMATRIX alone in participants with high-risk resected melanoma

Record identifier

TN_cdi_doaj_primary_oai_doaj_org_article_180a81075c10497e8c8ac926325f3b4e

https://collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_180a81075c10497e8c8ac926325f3b4e

Results of a randomized, double-blind phase II clinical trial of NY-ESO-1 vaccine with ISCOMATRIX adjuvant versus ISCOMATRIX alone in participants with high-risk resected melanoma

About this item

Full title

Results of a randomized, double-blind phase II clinical trial of NY-ESO-1 vaccine with ISCOMATRIX adjuvant versus ISCOMATRIX alone in participants with high-risk resected melanoma

Publisher

England: BMJ Publishing Group LTD

Journal title

Journal for immunotherapy of cancer, 2020, Vol.8 (1), p.e000410

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_180a81075c10497e8c8ac926325f3b4e

Language

English

Formats

Publication information

Publisher

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_180a81075c10497e8c8ac926325f3b4e

Permalink

https://collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_180a81075c10497e8c8ac926325f3b4e

Other Identifiers

ISSN

E-ISSN

DOI

How to access this item